Juventas is on the cutting edge of regenerative medicine and literally healing hearts, thanks to funding from Ohio Third Frontier. The Cleveland company just wrapped up phase two clinical trials, and its gene therapy could hit the market within the next five years. Watch the video:
Leave a Reply